skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Polyvalent Melanoma Vaccine (Code C1633)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Polyvalent Melanoma Vaccine

Definition: A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death. (NCI04)

Display Name: Polyvalent Melanoma Vaccine

Label: Polyvalent Melanoma Vaccine

NCI Thesaurus Code: C1633 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0299555  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Polyvalent Melanoma Cell Vaccine
Polyvalent Melanoma Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 43301
PDQ Open Trial Search ID 43301 (check for NCI PDQ open clinical trial info)
UMLS CUI C0299555

Other Properties:
     Name Value (qualifiers indented underneath)
code C1633
Contributing_Source CTRP
Legacy_Concept_Name Polyvalent_Melanoma_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom